Preview

Опухоли головы и шеи

Расширенный поиск

МЕТАСТАЗЫ ПЛОСКОКЛЕТОЧНОГО РАКА В ЛИМФАТИЧЕСКИЕ УЗЛЫ ШЕИ БЕЗ ВЫЯВЛЕННОГО ПЕРВИЧНОГО ОЧАГА

https://doi.org/10.17650/2222-1468-2012-0-4-53-58

Аннотация

В статье представлен обзор литературы по наиболее неизученной проблеме в онкологии опухолей головы и шеи — диагностике и лечению пациентов с метастазами в лимфатические узлы шеи без выявленного первичного очага.

Об авторе

О. А. Саприна
НИИ клинической онкологии ФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина» РАМН, Москва
Россия
Отделение опухолей черепно-челюстно-лицевой области


Список литературы

1. Рудык А.Н., Зинченко С.В., Хасанов Р.Ш. и др. Результаты диагностики и лечения больных с метастазами плоскоклеточного рака в лимфатические узлы шеи без выявленного первичного очага. Сибир онкол журн 2010;1(37).

2. Bell C.W., Pathak S., Frost P. Unknown primary tumors: establishment of cell lines, identification of chromosomal abnormalities, and implications for a second type of tumor progression. Cancer Res 1989 Aug 1;49(15):4311−5.

3. Guarischi A., Keane T.J., Elhakim T. Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases. Cancer 1987 Feb1;59(3):572−7.

4. Muir C. Cancer of unknown primary site. Cancer 1995 Jan 1;75(1 Suppl):353−6.

5. Seddon D.J., Williams E.M. Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry. Br J Cancer 1997; 76(5):667−74.

6. Bernal M.P., Cazar E.L., Estevez R.A. et al. Tumor primitivo desconocido. Rev Latinoamer Oncol Clin 1988;20(5):5−19.

7. Jungi W.F., Osterwalder B. Approach in metastasis with unknown primary tumor. Schweiz Med Wochenschr 1990 Sep 1; 120(35):1273−9.

8. Федотенко С.П. Метастазы рака в лимфатических узлах шеи без выявленного первичного очага (клиника, диагностика, лечение). Дис. … канд. мед. наук. М., 1978.

9. Cheng A.T.L., Dorman B. Fine needle aspiration cytology: the Auckland experience. Aust N Z J Surg 1992; 62(5):368−72.

10. Rapkiewicz A., Le B.T., Simsir A. et al. Spectrum of head and neck lesions diagnosed by fine-needle aspiration cytology in the pediatric population. Cancer 2007; 111(4):242−51.

11. Murthy P., Laing M.R., Palmer T.J. Fine needle aspiration cytology of head and neck lesions: an early experience. J R Coll Surg Edinb 1997;42(5):341−6.

12. Tandon S., Shahab R., Benton J.I. et al. Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis. Head Neck 2008;30(9):1246−52.

13. Howlett D.C., Harper B., Quante M., et al. Diagnostic adequacy and accuracy of fine needle aspiration cytology in neck lump assessment: results from a regional cancer network over a one year period. J Laryngol Otolog 2007;121(6):571−9.

14. Ellis E.R., Mendenhall W.M., Rao P.V., et al. Incisional or excisional neck-node biopsy before definitive radiotherapy, alone or followed by neck dissection. Head Neck 1991;13:177−83.

15. McGuirt W.F., Greven K., Williams D. III, et al. PET scanning in head and neck oncology: a review. Head Neck 1998;20(3):208−15.

16. Greven K.M., Keyes J.W. Jr, Williams D. III, et al. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer 1999;86(1):114−8.

17. Fogarty G.B., Peters L.J., Stewart J. et al. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck 2003;25(2):138−45.

18. Veit-Haibach P., Luczak C., Wanke I., et al. TNM staging with FDG-PET/CT in patients with primary head and neck cancer. Eur J Nucl Med Molecul Imaging 2007;34(12):1953−62.

19. Johansen J., Buus S., Loft A., et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the Dahanca-13 study. Head Neck 2008; 30(4):471−8.

20. Miller F.R., Karnad A.B., Eng T. et al. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008; 30(1):28−34.

21. Kothari P., Randhawa P.S., Farrell R. Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown primary in the head and neck. Br J Oral Maxillofac Surg 2008;46(4):283−7.

22. Jereczek-Fossa B.A., Jassem J., Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004; 30(2):153−64.

23. McQuone S.J., Eisele D.W., Lee D.-J. et al. Occult tonsillar carcinoma in the unknown primary. Laryngoscope 1998; 108(11):1605−10.

24. Randall D.A., Johnstone P.A.S., Foss R.D. et al. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg 2000; 122(1):52−5.

25. Kazak I., Haisch A., Jovanovic S. Bilateral synchronous tonsillar carcinoma in cervical cancer of unknown primary site (CUPS). Eur Arch Otorhinolaryngol 2003;260(9):490−3.

26. Koch W.M., Bhatti N., Williams M.F. et al. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001; 124(3):331−3.

27. Safa A.A., Tran L.M., Rege S., et al. The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am 1999;5:214−8.

28. Bataini J.P., Rodriguez J., Jaulerry C. et al. Treatment of metastatic neck nodes secondary to an occult epidermoid carcinoma of the head and neck. Laryngoscope 1987;97:1080−4.

29. Carlson L.S., Fletcher G.H., Oswald M.J. Guidelines for radiotherapeutic techniques for cervical metastases from an unknown primary. Int J Radiat Oncol Biol Phys 1986;12:2101−10.

30. Lefebvre J.L., Coche-Dequeant B., Van J.T. et al. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg 1990;160:443−6.

31. McCunniff A.J., Raben M. Metastatic carcinoma of the neck from an unknown primary. Int J Radiat Oncol Biol Phys 1986; 12:1849−52.

32. Reddy S.P., Marks J.E. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: Results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 1997;37:797−802.

33. Weir L., Keane T., Cummings B. et al. Radiation treatment of cervical lymph node metastases from an unknown primary: An analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 1995;35:206−11.

34. Abbruzzese J.L., Abbruzzese M.C., Hess K.R. et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994;12:1272−80.

35. LeChevalier T., Cvitkovic E., Caille P. et al. Early metastatic cancer of unknown primary origin at presentation. Arch Intern Med 1988;148:2035−9.

36. Lembersky B.C., Thomas L.C. Metastases of unknown primary site. Med Clin North Am 1996;80:153−71.

37. Muir С. Cancer of unknown primary site. Cancer 1995;1:353−6.

38. Pasterz R., Savoraj N., Burgess M. Prognostic factors in metastatic carcinoma of unknown primary. J Clin Oncol 1986; 4:1652−7.

39. Pentheroudakis G., Briasoulis E., Pavlidis N. Cancer of unknown primary site: missing primary or missing biology? Oncologist 2007;12:418−25.

40. Van de Wouw A.J., Janssen-Heijnen M.L., Coebergh J.W. et al. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984−1992. Eur J Cancer 2002;38:409−13.

41. Yalin Y., Pingzhang T., Smith G.I. et al. Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study. Br J Oral Maxillofac Surg 2002;40(6):484−7.

42. Klop W.M., Balm A.J., Keus R.B. et al. Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/ Antoni van Leeuwenhoek Hospital, 1979−98. Ned Tijdschr Genehieskd 2000; 144(28):1355−60.

43. Mistry R.C., Qureshi S.S., Talole S.D. et al. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary: outcomes and patterns of failure. Indian J Cancer 2008;8:54−8.

44. Iganej S., Kagan R., Anderson P. et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 2002;24(3):236−46.

45. Shukla P., Gupta D., Bisht S.S. et al. Metastatic squamous cell carcinoma neck with occult primary: A retrospective analysis. Indian J Med Paediatr Oncol 2009 Oct; 30(4):124−30.

46. Stenson K.M., Huo D., Blair E. et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 2006 Jan;116(1):33−6.

47. Argiris A., Smith S.M., Stenson K. et al. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 2003;14(8):1306−11.

48. Beldi D., Jereczek-Fossa B.A., D’Onofrio A. et al. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys 2007;69(4):1051−8.

49. Colletier P.J., Garden A.S., Morrison W.H., et al. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 1998;20:674−81.

50. Strojan P., Anicin A. Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour. Radiother Oncol 1998;49:33−40.

51. Medini E., Medini A.M., Lee C.K. et al. The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary. Am J Clin Oncol 1998;21:121−5.

52. Browman G.P., Hodson D.I., Mackenzie R.J., et al. Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579−89.

53. Bourhis J., Pignon J.P. Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? Hematol Oncol Clin North Am 1999;13:769−75.

54. Friesland S., Lind M.G., Lundgren J., et al. Outcome of ipsilateral treatment for patients with metastases to neck nodes of unknown origin. Acta Oncol 2001;40:24−8.

55. Grau C., Johansen L.V., Jakobsen J., et al. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000;55:121−9.

56. Erkal H.S., Mendenhall W.M., Amdur R.J., et al. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001;50:55−63.

57. Kirschner M.J., Fietkau R., Waldfahrer F., et al. Therapy of cervical lymph node metastases of unknown primary tumour. Strahlenther Onkol 1997;173:362−8.


Рецензия

Для цитирования:


Саприна О.А. МЕТАСТАЗЫ ПЛОСКОКЛЕТОЧНОГО РАКА В ЛИМФАТИЧЕСКИЕ УЗЛЫ ШЕИ БЕЗ ВЫЯВЛЕННОГО ПЕРВИЧНОГО ОЧАГА. Опухоли головы и шеи. 2012;(4):53-58. https://doi.org/10.17650/2222-1468-2012-0-4-53-58

For citation:


Saprina O.A. SQUAMOUS CELL CARCINOMA METASTASES TO THE CERVICAL LYMPH NODES WITHOUT A PRIMARY FOCUS BEING DETECTED. Head and Neck Tumors (HNT). 2012;(4):53-58. (In Russ.) https://doi.org/10.17650/2222-1468-2012-0-4-53-58

Просмотров: 1381


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2222-1468 (Print)
ISSN 2411-4634 (Online)